HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 175 | 209 | 83.7% | |
| HF 4 | 2012 | 164 | 204 | 80.4% | |
| HF 4 | 2013 | 182 | 213 | 85.5% | |
| HF004 | 2014 | 74 | 77 | 96.1% | |
| HF004 | 2015 | 80 | 83 | 96.4% | |
| HF004 | 2016 | 91 | 98 | 92.9% | |
| HF004 | 2017 | 124 | 128 | 96.9% | |
| HF004 | 2018 | 137 | 144 | 95.1% | |
| HF004 | 2019 | 211 | 223 | 94.6% | |
| HF004 | 2020 | 236 | 250 | 94.4% |
